Market Place
Sourcing Support
All News #Library
Biotech
InxMed’s Ifebemtinib Receive Breakthrough for NSCLC in China
21 Nov 2024 //
PR NEWSWIRE
InxMed Presents Data On Improving ADC Therapeutic At World ADC
07 Nov 2024 //
PR NEWSWIRE
InxMed Enters License Agreement with Escugen to Develop Next-Generation ADCs
19 Dec 2023 //
PR NEWSWIRE
InxMed Presents Data at 14th World ADC Highlighting Synergy of IN10018
18 Oct 2023 //
PR NEWSWIRE
InxMed Receives Approval PhI Trial China for OMTX705, a 1st-in-Class FAP ADC
29 Aug 2023 //
PR NEWSWIRE
GeneQuantum and InxMed have reached a technology licensing collaboration
17 Jul 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.